GENEVA, May 6 -- NATIONAL CANCER CENTER (1-1, Tsukiji 5-chome, Chuo-ku, Tokyo1040045), 国立研究開発法人国立がん研究センター (東京都中央区築地五丁目１番１号) filed a patent application (PCT/JP2024/038145) for "ANTIBODY AGAINST INTERLEUKIN-7 RECEPTOR (IL-7R), AND ANTIBODY-DRUG CONJUGATE (ADC) INCLUDING SAID ANTIBODY" on Oct 25, 2024. With publication no. WO/2025/089399, the details related to the patent application was published on May 01, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) syste...